nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—GRIA3—adrenal cortex—adrenal gland cancer	0.0174	0.114	CbGeAlD
Topiramate—GRIK3—pituitary gland—adrenal gland cancer	0.0159	0.104	CbGeAlD
Topiramate—GRIK5—pituitary gland—adrenal gland cancer	0.0159	0.104	CbGeAlD
Topiramate—GRIK3—adrenal gland—adrenal gland cancer	0.0142	0.0929	CbGeAlD
Topiramate—GRIK5—adrenal gland—adrenal gland cancer	0.0142	0.0929	CbGeAlD
Topiramate—CYP2C19—urine—adrenal gland cancer	0.0132	0.0861	CbGeAlD
Topiramate—GRIA3—adrenal gland—adrenal gland cancer	0.0126	0.0821	CbGeAlD
Topiramate—CYP3A4—urine—adrenal gland cancer	0.00779	0.0509	CbGeAlD
Topiramate—GRIK4—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00648	0.00765	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00603	0.00712	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00603	0.00712	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00582	0.00687	CbGpPWpGaD
Topiramate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.00554	0.00654	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00542	0.00639	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00532	0.00629	CbGpPWpGaD
Topiramate—GRIA2—N-cadherin signaling events—CDC42—adrenal gland cancer	0.00522	0.00616	CbGpPWpGaD
Topiramate—GRIA4—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00512	0.00605	CbGpPWpGaD
Topiramate—GRIA1—Amyotrophic lateral sclerosis (ALS)—BAD—adrenal gland cancer	0.00499	0.00589	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—PRKACA—adrenal gland cancer	0.00497	0.00586	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—PRKACA—adrenal gland cancer	0.00497	0.00586	CbGpPWpGaD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00495	0.00585	CbGpPWpGaD
Topiramate—GRIK5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00465	0.00549	CbGpPWpGaD
Topiramate—GRIK4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00465	0.00549	CbGpPWpGaD
Topiramate—CA5B—gonad—adrenal gland cancer	0.00463	0.0302	CbGeAlD
Topiramate—CA5B—cardiac atrium—adrenal gland cancer	0.00462	0.0302	CbGeAlD
Topiramate—GRIK3—Neuronal System—PRKACA—adrenal gland cancer	0.00462	0.00545	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—PRKACA—adrenal gland cancer	0.00462	0.00545	CbGpPWpGaD
Topiramate—SCN5A—cardiac atrium—adrenal gland cancer	0.00448	0.0293	CbGeAlD
Topiramate—GRIA1—Neuronal System—KCNJ5—adrenal gland cancer	0.00446	0.00527	CbGpPWpGaD
Topiramate—GRIK3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00432	0.0051	CbGpPWpGaD
Topiramate—GRIK1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00432	0.0051	CbGpPWpGaD
Topiramate—GRIA1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.00427	0.00504	CbGpPWpGaD
Topiramate—GABRG2—pituitary gland—adrenal gland cancer	0.00424	0.0277	CbGeAlD
Topiramate—GRIA3—BDNF signaling pathway—CDC42—adrenal gland cancer	0.00411	0.00485	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—KCNJ5—adrenal gland cancer	0.00408	0.00482	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00407	0.00481	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00407	0.0048	CbGpPWpGaD
Topiramate—CA5B—adrenal gland—adrenal gland cancer	0.00403	0.0264	CbGeAlD
Topiramate—GRIA4—Neuronal System—PRKACA—adrenal gland cancer	0.00393	0.00464	CbGpPWpGaD
Topiramate—GRIA3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00372	0.0044	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00372	0.00439	CbGpPWpGaD
Topiramate—GRIA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00367	0.00434	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00349	0.00412	CbGpPWpGaD
Topiramate—GRIK4—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00349	0.00412	CbGpPWpGaD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—IGF2—adrenal gland cancer	0.00336	0.00397	CbGpPWpGaD
Topiramate—CA9—HIF-1-alpha transcription factor network—ABCB1—adrenal gland cancer	0.00332	0.00392	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00325	0.00384	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00325	0.00383	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00325	0.00383	CbGpPWpGaD
Topiramate—CA2—adrenal cortex—adrenal gland cancer	0.0032	0.0209	CbGeAlD
Topiramate—CA4—cardiac atrium—adrenal gland cancer	0.00319	0.0208	CbGeAlD
Topiramate—GRIA2—Neuronal System—KCNJ5—adrenal gland cancer	0.00312	0.00368	CbGpPWpGaD
Topiramate—CA4—pituitary gland—adrenal gland cancer	0.00312	0.0204	CbGeAlD
Topiramate—GABRB2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00306	0.00361	CbGpPWpGaD
Topiramate—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00302	0.00357	CbGpPWpGaD
Topiramate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.00299	0.00353	CbGpPWpGaD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00297	0.0035	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—BAD—adrenal gland cancer	0.00287	0.00338	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—PRKACA—adrenal gland cancer	0.00285	0.00337	CbGpPWpGaD
Topiramate—CA9—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.00284	0.00335	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0028	0.0033	CbGpPWpGaD
Topiramate—CA4—adrenal gland—adrenal gland cancer	0.00278	0.0182	CbGeAlD
Topiramate—GRIA4—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00276	0.00326	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00271	0.0032	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—BRAF—adrenal gland cancer	0.00268	0.00316	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—BRAF—adrenal gland cancer	0.00268	0.00316	CbGpPWpGaD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00267	0.00315	CbGpPWpGaD
Topiramate—CA2—cardiac atrium—adrenal gland cancer	0.00264	0.0173	CbGeAlD
Topiramate—CA2—pituitary gland—adrenal gland cancer	0.00258	0.0169	CbGeAlD
Topiramate—GRIK1—Neuronal System—BRAF—adrenal gland cancer	0.00249	0.00294	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—BRAF—adrenal gland cancer	0.00249	0.00294	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—CDC42—adrenal gland cancer	0.00246	0.00291	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00244	0.00289	CbGpPWpGaD
Topiramate—GRIA2—N-cadherin signaling events—CTNNB1—adrenal gland cancer	0.0024	0.00283	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—KCNJ5—adrenal gland cancer	0.00234	0.00277	CbGpPWpGaD
Topiramate—CA2—adrenal gland—adrenal gland cancer	0.00231	0.0151	CbGeAlD
Topiramate—SCN1A—Developmental Biology—NR5A1—adrenal gland cancer	0.00224	0.00264	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00223	0.00263	CbGpPWpGaD
Topiramate—GRIA1—Amyotrophic lateral sclerosis (ALS)—TP53—adrenal gland cancer	0.00218	0.00258	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—KCNJ5—adrenal gland cancer	0.00214	0.00253	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—BRAF—adrenal gland cancer	0.00212	0.0025	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00208	0.00245	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00204	0.00241	CbGpPWpGaD
Topiramate—GRIA3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00201	0.00237	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.00189	0.00223	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—KCNJ5—adrenal gland cancer	0.00187	0.00221	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CDKN2A—adrenal gland cancer	0.00182	0.00215	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00173	0.00205	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—CDC42—adrenal gland cancer	0.00172	0.00203	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—BAD—adrenal gland cancer	0.00172	0.00203	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—PRKACA—adrenal gland cancer	0.00171	0.00202	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—PTGS2—adrenal gland cancer	0.0017	0.00201	CbGpPWpGaD
Topiramate—CA5A—Metabolism—SDHB—adrenal gland cancer	0.0017	0.00201	CbGpPWpGaD
Topiramate—CA6—Metabolism—SDHB—adrenal gland cancer	0.0017	0.00201	CbGpPWpGaD
Topiramate—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00166	0.00196	CbGpPWpGaD
Topiramate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00165	0.00195	CbGpPWpGaD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.0016	0.00189	CbGpPWpGaD
Topiramate—CA7—Metabolism—SDHB—adrenal gland cancer	0.00159	0.00187	CbGpPWpGaD
Topiramate—CA5B—Metabolism—SDHB—adrenal gland cancer	0.00159	0.00187	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NR5A1—adrenal gland cancer	0.00157	0.00186	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—PRKACA—adrenal gland cancer	0.00156	0.00185	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00156	0.00184	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00156	0.00184	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—BRAF—adrenal gland cancer	0.00154	0.00182	CbGpPWpGaD
Topiramate—CA12—Metabolism—SDHB—adrenal gland cancer	0.00147	0.00173	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00146	0.00173	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00143	0.00168	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MED12—adrenal gland cancer	0.00134	0.00159	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00125	0.00147	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0012	0.00142	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—BAD—adrenal gland cancer	0.0012	0.00142	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—PRKACA—adrenal gland cancer	0.0012	0.00141	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00117	0.00138	CbGpPWpGaD
Topiramate—CA4—Metabolism—SDHB—adrenal gland cancer	0.00117	0.00138	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—CDC42—adrenal gland cancer	0.00117	0.00138	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00114	0.00135	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.00113	0.00133	CbGpPWpGaD
Topiramate—CA2—Metabolism—SDHB—adrenal gland cancer	0.00112	0.00133	CbGpPWpGaD
Topiramate—SCN1A—L1CAM interactions—EGFR—adrenal gland cancer	0.00112	0.00133	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00112	0.00132	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0011	0.0013	CbGpPWpGaD
Topiramate—CA6—Metabolism—SDHD—adrenal gland cancer	0.00109	0.00129	CbGpPWpGaD
Topiramate—CA5A—Metabolism—RRM1—adrenal gland cancer	0.00109	0.00129	CbGpPWpGaD
Topiramate—CA5A—Metabolism—SDHD—adrenal gland cancer	0.00109	0.00129	CbGpPWpGaD
Topiramate—CA6—Metabolism—RRM1—adrenal gland cancer	0.00109	0.00129	CbGpPWpGaD
Topiramate—CA1—Metabolism—SDHB—adrenal gland cancer	0.00108	0.00127	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00107	0.00127	CbGpPWpGaD
Topiramate—CA5B—Metabolism—RRM1—adrenal gland cancer	0.00102	0.00121	CbGpPWpGaD
Topiramate—CA5B—Metabolism—SDHD—adrenal gland cancer	0.00102	0.00121	CbGpPWpGaD
Topiramate—CA7—Metabolism—RRM1—adrenal gland cancer	0.00102	0.00121	CbGpPWpGaD
Topiramate—CA7—Metabolism—SDHD—adrenal gland cancer	0.00102	0.00121	CbGpPWpGaD
Topiramate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000997	0.00118	CbGpPWpGaD
Topiramate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00095	0.00112	CbGpPWpGaD
Topiramate—CA9—Metabolism—SDHB—adrenal gland cancer	0.000947	0.00112	CbGpPWpGaD
Topiramate—CA12—Metabolism—RRM1—adrenal gland cancer	0.000947	0.00112	CbGpPWpGaD
Topiramate—CA12—Metabolism—SDHD—adrenal gland cancer	0.000947	0.00112	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MED12—adrenal gland cancer	0.000945	0.00112	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.000937	0.00111	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—BRAF—adrenal gland cancer	0.000921	0.00109	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—PRKACA—adrenal gland cancer	0.000898	0.00106	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—BRAF—adrenal gland cancer	0.000842	0.000994	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000841	0.000993	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00084	0.000992	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CDC42—adrenal gland cancer	0.000832	0.000982	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—PRKACA—adrenal gland cancer	0.000821	0.000969	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—CDC42—adrenal gland cancer	0.00082	0.000968	CbGpPWpGaD
Topiramate—CA6—Metabolism—MED12—adrenal gland cancer	0.000816	0.000963	CbGpPWpGaD
Topiramate—CA5A—Metabolism—MED12—adrenal gland cancer	0.000816	0.000963	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.00079	0.000933	CbGpPWpGaD
Topiramate—SCN5A—L1CAM interactions—EGFR—adrenal gland cancer	0.000789	0.000932	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.000768	0.000907	CbGpPWpGaD
Topiramate—CA7—Metabolism—MED12—adrenal gland cancer	0.000762	0.000899	CbGpPWpGaD
Topiramate—CA5B—Metabolism—MED12—adrenal gland cancer	0.000762	0.000899	CbGpPWpGaD
Topiramate—CA4—Metabolism—SDHD—adrenal gland cancer	0.000755	0.000891	CbGpPWpGaD
Topiramate—CA4—Metabolism—RRM1—adrenal gland cancer	0.000755	0.000891	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—RB1—adrenal gland cancer	0.000729	0.000861	CbGpPWpGaD
Topiramate—CA2—Metabolism—RRM1—adrenal gland cancer	0.000724	0.000854	CbGpPWpGaD
Topiramate—CA2—Metabolism—SDHD—adrenal gland cancer	0.000724	0.000854	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—PRKACA—adrenal gland cancer	0.000718	0.000847	CbGpPWpGaD
Topiramate—CA12—Metabolism—MED12—adrenal gland cancer	0.000706	0.000833	CbGpPWpGaD
Topiramate—CA1—Metabolism—RRM1—adrenal gland cancer	0.000694	0.000819	CbGpPWpGaD
Topiramate—CA1—Metabolism—SDHD—adrenal gland cancer	0.000694	0.000819	CbGpPWpGaD
Topiramate—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000688	0.000813	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000675	0.000797	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.000671	0.000793	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—BRAF—adrenal gland cancer	0.000644	0.00076	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CDKN2A—adrenal gland cancer	0.000641	0.000757	CbGpPWpGaD
Topiramate—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000635	0.00075	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000631	0.000745	CbGpPWpGaD
Topiramate—CA9—Metabolism—RRM1—adrenal gland cancer	0.00061	0.00072	CbGpPWpGaD
Topiramate—CA9—Metabolism—SDHD—adrenal gland cancer	0.00061	0.00072	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PRKACA—adrenal gland cancer	0.000595	0.000703	CbGpPWpGaD
Topiramate—CA6—Metabolism—PRKACA—adrenal gland cancer	0.000595	0.000703	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CDC42—adrenal gland cancer	0.000585	0.000691	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000578	0.000682	CbGpPWpGaD
Topiramate—CA4—Metabolism—MED12—adrenal gland cancer	0.000563	0.000664	CbGpPWpGaD
Topiramate—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000558	0.000659	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PRKACA—adrenal gland cancer	0.000556	0.000656	CbGpPWpGaD
Topiramate—CA7—Metabolism—PRKACA—adrenal gland cancer	0.000556	0.000656	CbGpPWpGaD
Topiramate—CA2—Metabolism—MED12—adrenal gland cancer	0.00054	0.000637	CbGpPWpGaD
Topiramate—CA1—Metabolism—MED12—adrenal gland cancer	0.000517	0.000611	CbGpPWpGaD
Topiramate—CA12—Metabolism—PRKACA—adrenal gland cancer	0.000515	0.000608	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000505	0.000596	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—BRAF—adrenal gland cancer	0.000484	0.000571	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000483	0.00057	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GNAS—adrenal gland cancer	0.000482	0.00057	CbGpPWpGaD
Topiramate—CA6—Metabolism—GNAS—adrenal gland cancer	0.000482	0.00057	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ABCB1—adrenal gland cancer	0.000473	0.000559	CbGpPWpGaD
Topiramate—CA6—Metabolism—ABCB1—adrenal gland cancer	0.000473	0.000559	CbGpPWpGaD
Topiramate—CA9—Metabolism—MED12—adrenal gland cancer	0.000455	0.000537	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GNAS—adrenal gland cancer	0.00045	0.000532	CbGpPWpGaD
Topiramate—CA7—Metabolism—GNAS—adrenal gland cancer	0.00045	0.000532	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000445	0.000525	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—BRAF—adrenal gland cancer	0.000442	0.000522	CbGpPWpGaD
Topiramate—CA7—Metabolism—ABCB1—adrenal gland cancer	0.000442	0.000522	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ABCB1—adrenal gland cancer	0.000442	0.000522	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000441	0.000521	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—EGFR—adrenal gland cancer	0.000424	0.000501	CbGpPWpGaD
Topiramate—CA12—Metabolism—GNAS—adrenal gland cancer	0.000417	0.000493	CbGpPWpGaD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000414	0.000489	CbGpPWpGaD
Topiramate—CA4—Metabolism—PRKACA—adrenal gland cancer	0.000411	0.000485	CbGpPWpGaD
Topiramate—CA12—Metabolism—ABCB1—adrenal gland cancer	0.000409	0.000483	CbGpPWpGaD
Topiramate—CA2—Metabolism—PRKACA—adrenal gland cancer	0.000394	0.000465	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000391	0.000462	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—BRAF—adrenal gland cancer	0.000387	0.000457	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000386	0.000456	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000384	0.000453	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CTNNB1—adrenal gland cancer	0.000382	0.000451	CbGpPWpGaD
Topiramate—CA1—Metabolism—PRKACA—adrenal gland cancer	0.000377	0.000446	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000358	0.000422	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—adrenal gland cancer	0.000357	0.000421	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000351	0.000415	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000336	0.000396	CbGpPWpGaD
Topiramate—CA4—Metabolism—GNAS—adrenal gland cancer	0.000333	0.000393	CbGpPWpGaD
Topiramate—CA9—Metabolism—PRKACA—adrenal gland cancer	0.000332	0.000392	CbGpPWpGaD
Topiramate—CA4—Metabolism—ABCB1—adrenal gland cancer	0.000327	0.000386	CbGpPWpGaD
Topiramate—CA6—Metabolism—POMC—adrenal gland cancer	0.000325	0.000384	CbGpPWpGaD
Topiramate—CA5A—Metabolism—POMC—adrenal gland cancer	0.000325	0.000384	CbGpPWpGaD
Topiramate—CA2—Metabolism—GNAS—adrenal gland cancer	0.000319	0.000377	CbGpPWpGaD
Topiramate—CA2—Metabolism—ABCB1—adrenal gland cancer	0.000313	0.00037	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000313	0.000369	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000307	0.000362	CbGpPWpGaD
Topiramate—CA1—Metabolism—GNAS—adrenal gland cancer	0.000306	0.000361	CbGpPWpGaD
Topiramate—CA5B—Metabolism—POMC—adrenal gland cancer	0.000303	0.000358	CbGpPWpGaD
Topiramate—CA7—Metabolism—POMC—adrenal gland cancer	0.000303	0.000358	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EGFR—adrenal gland cancer	0.000303	0.000357	CbGpPWpGaD
Topiramate—CA1—Metabolism—ABCB1—adrenal gland cancer	0.0003	0.000354	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—EGFR—adrenal gland cancer	0.000298	0.000352	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000296	0.00035	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000286	0.000338	CbGpPWpGaD
Topiramate—CA12—Metabolism—POMC—adrenal gland cancer	0.000281	0.000332	CbGpPWpGaD
Topiramate—CA9—Metabolism—GNAS—adrenal gland cancer	0.000269	0.000317	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CTNNB1—adrenal gland cancer	0.000269	0.000317	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.000265	0.000313	CbGpPWpGaD
Topiramate—CA9—Metabolism—ABCB1—adrenal gland cancer	0.000264	0.000312	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTGS2—adrenal gland cancer	0.000259	0.000306	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTGS2—adrenal gland cancer	0.000259	0.000306	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTGS2—adrenal gland cancer	0.000242	0.000286	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTGS2—adrenal gland cancer	0.000242	0.000286	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—adrenal gland cancer	0.000224	0.000265	CbGpPWpGaD
Topiramate—CA4—Metabolism—POMC—adrenal gland cancer	0.000224	0.000265	CbGpPWpGaD
Topiramate—CA2—Metabolism—POMC—adrenal gland cancer	0.000215	0.000254	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EGFR—adrenal gland cancer	0.000213	0.000251	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000209	0.000246	CbGpPWpGaD
Topiramate—CA1—Metabolism—POMC—adrenal gland cancer	0.000206	0.000243	CbGpPWpGaD
Topiramate—CA9—Metabolism—POMC—adrenal gland cancer	0.000181	0.000214	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—adrenal gland cancer	0.000179	0.000211	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000178	0.00021	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—adrenal gland cancer	0.000171	0.000202	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.000171	0.000202	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.000171	0.000202	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—adrenal gland cancer	0.000164	0.000194	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000159	0.000188	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—adrenal gland cancer	0.000144	0.00017	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000127	0.00015	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000114	0.000134	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000103	0.000121	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000103	0.000121	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	9.29e-05	0.00011	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	9.08e-05	0.000107	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MED12—adrenal gland cancer	7.66e-05	9.04e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GNAS—adrenal gland cancer	7.53e-05	8.89e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	7.39e-05	8.72e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	5.59e-05	6.59e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—POMC—adrenal gland cancer	5.07e-05	5.98e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GNAS—adrenal gland cancer	4.53e-05	5.34e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	4.44e-05	5.24e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	4.04e-05	4.77e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—POMC—adrenal gland cancer	3.05e-05	3.6e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	2.43e-05	2.87e-05	CbGpPWpGaD
